WebMD's Hansa Bhargava asks CDC's Tom Frieden to comment on current issues in infectious diseases and the changing microbial landscape.

Among Dr Goldhaber's highlights are better risk stratification and the inclusion of the novel oral anticoagulants.

If your facility hasn't adopted the third-edition bundles from the Surviving Sepsis Campaign, here are the details you need.

Ileana Piña explains the role of BNP in heart failure management today and what she hopes to learn from the GUIDE-IT study.

What are the pros and cons of using thrombolytics in PE patients?

Dr. David Kerr thoughtfully responds to news that religious leaders support a proposed UK law for physician-assisted suicide and ponders whether he could offer his cancer patients this option.

A new study looks at the safety of restarting anticoagulation following intracranial hemorrhage.

Recent trials show the first successful treatments for idiopathic pulmonary fibrosis. Exciting news for this fatal disease, but success rates must be interpreted with caution, says Dr. Andrew Shorr.

Dr. Piña reviews a subgroup analysis from the TOPCAT trial, and explains why she thinks spironolactone has a role in many patients with heart failure.

Dr. Hans-Christoph Diener looks at results presented at the 2014 European Stroke Conference – have we "reached a ceiling of clinical benefit"?